Clarus Wealth Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,000
Closed -$377K 110
2021
Q1
$377K Hold
3,000
0.24% 80
2020
Q4
$432K Hold
3,000
0.29% 64
2020
Q3
$311K Hold
3,000
0.24% 92
2020
Q2
$259K Buy
+3,000
New +$240K 0.22% 99
2020
Q1
Sell
-3,000
Closed -$311K 122
2019
Q4
$311K Hold
3,000
0.21% 105
2019
Q3
$271K Buy
+3,000
New +$342K 0.2% 108

Other funds holding EXAS

Clarus Wealth Advisors's EXAS Position: Q2 2021 in Review

Clarus Wealth Advisors sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 3,000 shares — an estimated $377K sold.

Clarus Wealth Advisors first reported a position in EXAS in Q3 2019 and held it in 6 quarters. The position peaked at $432K in Q4 2020. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Clarus Wealth Advisors reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Clarus Wealth Advisors sold 3,000 Exact Sciences shares in Q2 2021, an estimated $377K.
  • Clarus Wealth Advisors first reported a position in Exact Sciences in Q3 2019 and held it in 6 quarters.
  • Clarus Wealth Advisors's Exact Sciences position peaked at $432K in Q4 2020.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Clarus Wealth Advisors's 13F filing for Q2 2021, filed 13 Jul 2021.